Alex Goldberg

NYSE Decliners Watch List: Abbott Laboratories (NYSE:ABT) and Philip Morris International, Inc. (NYSE:PM) Added to Equity Profile Report's NYSE Decliners Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/20/2014 -- Equity Profile Report expands its NYSE Decliners Weekly Watch List adding Abbott Laboratories (NYSE:ABT) and Philip Morris International, Inc. (NYSE:PM).

Abbott Laboratories (NYSE:ABT) a company that engages in the discovery, development, manufacture, and sale of health care products worldwide closed down in its previous session (-0.44%) on 7,093,216 shares traded. Abbott Laboratories (NYSE:ABT) is currently down (-2.96%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Abbott Laboratories (NYSE:ABT)

Philip Morris International, Inc. (NYSE:PM) a company that through its subsidiaries, manufactures and sells cigarettes and other tobacco products closed down in its previous session (-0.51%) on 4,469,658 shares traded. Philip Morris International, Inc. (NYSE:PM) is currently down (-17.81%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.

Click Here to find out what other Investors are saying about Philip Morris International, Inc. (NYSE:PM)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com